The Diffuse Mesothelioma Payment Scheme (DMPS) is designed to provide compensation for people suffering from diffuse mesothelioma, a cancer tied to exposure to asbestos, or for the families of those who have died. It is a scheme for people who were negligently exposed to asbestos at work and who are unable to trace their employer or their employer’s insurer after their diagnosis.
DMPS is funded by a levy on the Employers’ Liability Compulsory Insurance industry, set this year at £40.4 million. This is higher than previous years to balance out an under-levy from last year and to reflect that the average payment per applicant has been getting higher. The latest official statistics for the scheme will be published on 31 January 2017.